Insulin is skipped, stretched, or stopped when out-of-pocket costs collide with tight budgets, often leading to higher blood sugar and urgent complications.
Most people don’t call it “underuse.” They call it “making it last.” One less unit. One fewer correction. One more day before the refill. It can feel like a small trade, then it stacks up fast.
When insulin costs rise above what a household can pay, people start making painful choices. Some delay fills. Some take smaller doses. Some use an older plan that doesn’t match their needs. These aren’t “bad habits.” They’re budget math.
This article breaks down what cost-related insulin underuse looks like, why it happens, what it does to the body, and how patients and clinics can reduce the risk without shame or guesswork.
What Cost-Related Insulin Underuse Means In Real Life
Cost-related insulin underuse is a plain idea: insulin is taken differently than prescribed because it costs too much. That can show up in a few common patterns.
Common Underuse Patterns People Report
- Taking less insulin per dose to stretch a pen or vial
- Skipping doses, especially at meals or overnight
- Delaying refill pickup until payday
- Not starting a new insulin type that was prescribed
- Switching to a cheaper insulin plan without a clear transition plan
Underuse can happen in type 1 diabetes and type 2 diabetes. The reasons overlap, even when the insulin plan differs.
Why The Word “Rationing” Fits
“Rationing” isn’t a dramatic label. It describes the action: distributing a limited supply across more days than it was meant to cover. People do it when they fear running out.
It also explains why some patients don’t tell anyone. Saying “I ration insulin” can feel like admitting failure. Many patients stay quiet until blood sugar runs high, symptoms show up, or a refill is overdue by weeks.
How Costs Push People Into Insulin Underuse
Insulin pricing can be confusing, even for people who work in health care. The number on the pharmacy receipt is shaped by plan rules, deductible status, coinsurance, and which insulin is on the formulary.
The Most Common Cost Pressure Points
- Deductibles: Early in the year, people may pay full or near-full price until the deductible is met.
- Formulary switches: Plans can prefer one insulin brand, then change. The “preferred” option can shift midyear.
- Prior authorization: Delays can turn into missed doses when a refill is stuck in paperwork.
- Coinsurance: A percentage-based copay can jump when list prices rise.
- Supply costs: Pens, needles, CGM sensors, pump sets, and strips can add up alongside insulin.
Even insured patients can get squeezed. If the plan design puts high costs on the patient early in the year or pushes certain brands, the out-of-pocket amount can spike in ways families didn’t plan for.
Why People Often Underuse In Predictable Windows
Clinics hear the same timing cues again and again: January and February (deductibles), the week before rent is due, the stretch between paychecks, or a month when another expense hits hard.
That pattern matters because it gives clinicians and patients a chance to plan ahead, not react after the fact.
What Underuse Does To Blood Sugar And Daily Safety
Insulin isn’t a “nice to have.” For type 1 diabetes, it’s required for survival. For many people with type 2 diabetes, it’s the tool that keeps glucose in range when other medicines aren’t enough.
Short-Term Effects That Show Up Fast
- High blood glucose (hyperglycemia) that lasts for hours or days
- Dehydration, fatigue, blurry vision, headaches
- More urination and thirst that disrupt sleep
- Nausea and abdominal discomfort as ketones rise
Serious Risks When Insulin Is Repeatedly Skipped
Repeated under-dosing can increase the risk of emergency care. For some patients, the danger is diabetic ketoacidosis (DKA), a life-threatening state that can develop when insulin is too low for the body’s needs.
It can also lead to high A1C over time, which raises the risk of complications affecting eyes, kidneys, nerves, and heart. The longer underuse continues, the more the “quiet” damage can build.
Cost-Related Underuse Links With Poorer Glycemic Control
Research on cost-related insulin underuse has found that a meaningful share of patients report underuse due to cost, and those patients are more likely to have poor glycemic control. That link is not surprising: insulin plans are designed with specific dosing in mind, and repeated gaps can move glucose out of range.
Cost-Related Insulin Underuse Among Patients With Diabetes With Added Risk Signals
Not every patient faces the same risk of cost-driven underuse. Some signals show up more often in clinic settings and in research surveys. A clinician who asks the right questions can spot trouble early.
Use this as a practical map. It’s not a moral judgment. It’s a risk screen.
Table: Cost Drivers, Underuse Behaviors, And What They Often Lead To
| Cost Or Access Pressure | What Patients May Do | Common Downstream Outcome |
|---|---|---|
| High deductible period | Delay refills; stretch doses | Days of persistent hyperglycemia |
| Formulary change | Skip while waiting for a new script | Missed basal coverage or meal doses |
| Prior authorization delay | Use leftovers; take less per dose | Glucose volatility; ketone risk |
| High coinsurance | Try to make one pen last longer | Higher A1C across months |
| Lost coverage or plan gap | Stop insulin for a period | Urgent care visit; DKA risk |
| Rising supply costs (CGM/pump/needles) | Cut back on testing or supplies | Less data, more dosing errors |
| Transportation or pharmacy access problems | Pick up late; miss doses during gaps | Repeated high glucose “patches” |
| Food insecurity or unstable income | Skip insulin when meals are skipped | Unsafe swings, hypoglycemia risk later |
| Fear of talking about cost | Underuse in silence | Clinician can’t adjust plan in time |
Two patterns stand out. First, underuse often starts during predictable financial strain. Second, silence makes it worse. When no one knows the plan is failing, no one can patch it.
How Clinicians Can Ask About Cost Without Shame
Cost questions can be asked like any other safety question. The goal is to remove blame and get clean information fast.
Patient-Ready Questions That Work
- “Have you ever taken less insulin than prescribed so it would last longer?”
- “Have you delayed a refill in the past year because the pharmacy price was too high?”
- “Which month is hardest for medicine costs: early year, midyear, or late year?”
- “Do you want us to write a plan that fits your budget and still keeps glucose safe?”
These questions treat underuse as a system problem. They also open the door for options like switching to a lower-cost insulin with a clear transition plan, using patient assistance programs, or aligning prescriptions with coverage rules.
One widely cited survey study in an urban diabetes center reported that roughly one in four patients described cost-related insulin underuse, and many had not talked with a clinician about it. You can read the full study here: JAMA Internal Medicine: “Cost-Related Insulin Underuse Among Patients With Diabetes”.
Practical Ways Patients Can Lower Insulin Costs Without Gambling With Health
Not every option fits every person. Still, there are common steps that can reduce out-of-pocket costs. The best results come from pairing cost fixes with a dosing plan that stays safe.
Start With The Pharmacy Receipt Details
Ask the pharmacy what drove the price: deductible, coinsurance, non-preferred brand, or quantity limits. The reason matters because the fix changes with the cause.
Use Coverage Rules To Your Advantage
Many plans prefer certain insulin products. If a prescribed insulin is non-preferred, the copay can jump. A clinician can often prescribe a preferred option that still matches the patient’s clinical needs, with a clear titration plan.
The American Diabetes Association keeps a consumer-facing page that lists common affordability routes, including coverage and assistance pointers. See: ADA: “Insulin Cost & Affordability”.
Check Whether You Qualify For A Monthly Cap
In the U.S., some Medicare insulin costs have been capped in recent years for many enrollees, which can change what patients pay at the counter. Rules differ by Part B versus Part D and by delivery method.
For broader day-to-day diabetes care planning, including medicine routines and glucose monitoring habits, the National Institute of Diabetes and Digestive and Kidney Diseases provides a plain-language overview here: NIDDK: “Managing Diabetes”.
Build A “No-Gap” Refill Routine
Even when costs are under control, refill gaps still happen. A simple routine can cut risk:
- Refill when you have 10–14 days left, not when you’re down to the last few doses.
- Set a calendar alert for refill day and pickup day.
- Keep one backup plan written down: which pharmacy can transfer, which clinician line to call, which insulin is acceptable if the preferred brand changes.
This routine sounds basic. It works because it removes “last-minute” pressure when something goes wrong.
Table: Options To Reduce Out-Of-Pocket Costs And The Trade-Off To Watch
| Cost-Lowering Option | When It Often Fits | Trade-Off To Watch |
|---|---|---|
| Switch to a formulary-preferred insulin | Copay is high due to non-preferred brand | Needs a clear conversion and titration plan |
| 90-day supply (mail or retail) | Plan allows lower per-month cost on longer fills | Higher upfront payment in one visit |
| Manufacturer savings card (commercial insurance) | Patient is eligible and insulin is covered | May not apply to government plans |
| Patient assistance program | Income and coverage rules qualify | Paperwork time; renewal dates |
| Clinic social services or pharmacy team referral | Complex coverage barriers or repeated refill gaps | Needs follow-through and documentation |
| Review devices and supplies costs | Supplies are the hidden monthly drain | Cutting supplies can reduce data for dosing |
| State or plan-specific insulin caps | Caps apply to that plan and insulin category | Cap may not cover every product or scenario |
| Bridge prescription or emergency refill policy | Short gap due to paperwork delay | Not always available; varies by region and plan |
Notice the repeated theme: a cost fix is only “safe” when the dosing plan stays matched to the patient’s physiology and daily routine. Swaps without coaching can backfire.
How Patients Can Talk About Underuse Without Feeling Judged
Here’s a simple script that often lands well:
“I’m running short before refill day. I’ve been taking less so it lasts. I don’t want to keep doing that. Can we make a plan I can afford?”
This tells the truth and asks for a plan. It also signals that the goal is safety, not arguing.
Bring A Few Details To The Visit
- What you paid for the last fill
- When you started stretching or skipping
- Which doses you cut first (basal, meals, corrections)
- Any recent high readings, ketones, or symptoms
If you track glucose, bring the last 14 days. If you don’t, bring what you can: a few readings and a clear story of when you felt unwell. A clinician can work with that.
Clinic-Level Steps That Reduce Underuse Rates
Underuse drops when clinics treat affordability as routine care, not a special request. A few workflow changes can make a real difference.
Build Cost Screening Into Every Insulin Visit
Add one question to intake: “Any trouble paying for insulin or diabetes supplies in the last 12 months?” If the answer is yes, route the patient to a clear pathway: pharmacy team, benefits check, assistance applications, or a safer insulin alternative.
Make “Refill Failure” A Clinical Signal
Late refills often show up before a crisis. Treat a late refill like a safety flag, the same way you’d treat repeated hypoglycemia. The fix is not blame. The fix is adjusting the plan to match reality.
Use Plain Guidance On Diabetes Self-Management
People under financial strain have less bandwidth for complicated instructions. Clear routines matter: how to take insulin, what to do when you’re low on supply, and when to seek urgent care.
For a public-health view of diabetes burden and related behaviors, CDC research in its diabetes publications often includes medication underuse measures. One example that includes cost-related medication/insulin underuse variables is here: CDC Preventing Chronic Disease article including cost-related medication/insulin underuse measures.
When To Treat Underuse As An Emergency
If insulin has been stopped for more than a short gap, or if blood sugar is high with symptoms, it’s time to act fast. Seek urgent medical care right away if any of these show up:
- Vomiting, severe abdominal pain, or rapid breathing
- Moderate to large ketones (if you can test)
- Confusion or extreme weakness
- Signs of dehydration: dizziness, dry mouth, little urine
These can be signs of DKA or severe hyperglycemia, which can turn dangerous quickly. Don’t wait for a scheduled visit in that situation.
A Safer Way Forward: Match The Insulin Plan To The Budget
Cost-related insulin underuse is a solvable problem when it’s treated as routine care. The core moves are simple:
- Ask about affordability early, before gaps pile up.
- Name the exact failure point: deductible, formulary, delay, coinsurance, supply costs.
- Pick a cost path that fits the patient’s coverage and daily life.
- Write the dosing plan clearly, including what to do during a refill gap.
Patients deserve an insulin plan that works on paper and at the pharmacy counter. When those two match, glucose control becomes a lot more realistic.
References & Sources
- JAMA Internal Medicine.“Cost-Related Insulin Underuse Among Patients With Diabetes.”Defines cost-related insulin underuse behaviors and reports an association with poorer glycemic control in a surveyed clinic population.
- American Diabetes Association (ADA).“Insulin Cost & Affordability.”Lists affordability routes and practical pathways patients can use to reduce insulin costs under different coverage situations.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).“Managing Diabetes.”Provides a plain-language overview of diabetes care routines that pair with safe medication use and glucose management.
- Centers for Disease Control and Prevention (CDC).“Diabetes Distress Among US Adults With Diagnosed Diabetes” (includes cost-related medication/insulin underuse measures).Includes survey measures used in public-health research that capture cost-related medication/insulin underuse.